Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Dave Morehead
Individual Investor

Dave Morehead

Overview

Edit Overview Section
Number of Portfolio Companies 1
Number of Current Board & Advisor Roles 1
  • Investor Type 
    obfuscation
Dave Morehead, who has been a limited partner in several top biotech venture funds and leads Baylor University’s $2.5 billion endowment.

Personal Investments

Edit Personal Investments Section
Number of Investments 1
Dave Morehead invested in Breakthru Medicine on
obfuscation
. This investment - Series A - Breakthru Medicine - was valued at
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Breakthru Medicine Logo
Breakthru Medicine
—
Series A - Breakthru Medicine Logo
Series A - Breakthru Medicine
obfuscation

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 1
Dave Morehead is the Board Member at Breakthru Medicine.

Recent News and Activity

Edit Recent News and Activity Section
Funding Round•Jan 29, 2026
Breakthru Medicine raised
obfuscation
from Dave Morehead and 2 other investors
Discover more funding rounds
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|